7th Annual Outsourcing in Clinical Trials DACH 2024

Providing a specific platform for the clinical trials community in the DACH region to develop innovative clinical operations and outsourcing strategies.

29 - 30

October

2024
  • Hyatt Regency Zurich Airport The Circle, Zurich, Switzerland
  • Ticketed
  • Why attend?
  • Agenda
  • Speakers
  • Plan Your Visit
  • Event Gallery
  • Sponsors
  • Media Centre
  • Why partner?
  • Contact Us
close

Featured Speakers

Back

Robert Corbé​

Evidence Delivery Associate Director, AstraZeneca

Robert Corbé is an Evidence Delivery Associate Director at AstraZeneca with over 20 years of experience from Pharma, Med Tech and Bio Tech companies. In the current role he is responsible for the operational delivery of Phase IV and Observational studies. In addition he is the Patent Safety Subject Matter Expert for all post marketing studies within AstraZeneca BioPharmaceuticals. By focusing on both study delivery and safety data collection he can support the AstraZeneca study teams to achieve their delivery goals with the appropriate level of safety data collection to comply with both business needs and regulatory requirements.

Next speaker
Back

Dr. Frank Richard​

MD, MBA, Senior Medical Director, Sotio Biotech

Next speaker
Back

Francois Curtin​

CMO/Medical Director for Personalized Health Programmes, Swiss Federal Institute of Technology Zurich

Next speaker
Back

Giulia Rancati​

Market Solutions Lead for R&D, Roche

Giulia Rancati worked across biotech, academia and government organisations in the USA, Europe and South-East Asia. In 2021, she then transitioned to F. Hoffmann - La Roche where she leads the R&D Market Solutions Lead in Insights and Solutions. Here, Giulia is coaching a global team that focuses on co-creating and delivering R&D solutions to increase preclinical and clinical efficiency.

Next speaker
Back

Rolf Banholzer​

Global Head Development Operations QA, Novartis Pharma

Next speaker
Back

Sotirios Perdikeas​

Global Head Resource Management & Analytics, Strategy, Portfolio & Clinical Operations, Roche

Next speaker

    Sponsors Include:

    Back

    Company Information

    Medidata is powering smarter treatments and healthier people through digital solutions to support clinical trials. Celebrating 25 years of ground-breaking technological innovation across more than 33,000 trials and 10 million patients, Medidata offers industry-leading expertise, analytics-powered insights, and the largest patient-level historical clinical trial data set in the world. More than 1 million registered users across 2,200+ customers trust Medidata’s seamless, end-to-end platform to improve patient experiences, accelerate clinical breakthroughs, and bring therapies to market faster.

    Company Website

    To learn more , please visit our website - https://www.medidata.com

    Next Sponsor
    Back

    Company Information

    1MED, is the leading European MedTech specialized solutions provider,
    offering end-to-end development expertise within the medical device, novel technology and combination products fields.

    Founded in 2014, with headquarter in Agno, Switzerland, and employing 100+ professionals across the Europe, 1MED’s mission is to support all the MedTech organizations in facing the complexity associated with the development of innovative medical devices in compliance with MDR.

    Such support may include providing preclinical support, regulatory advice, clinical study management, post marketing support, digital solutions and quality management systems across the clinical research continuum with a cross-functional approach which led to win the certification and certification maintenance of more than 500 different medical devices within the last 5 years.

    Company Website

    To learn more , please visit our website - https://www.1med.ch/

    Next Sponsor
    Back

    Company Information

    We’re more than a supplier: we’re a partner that can deliver consistent quality and superior service, a partner that fuel innovation for foster real and sustainable results. A deep understanding of healthcare industry and our customers’ needs is critical to ensure our range of packaging products and services deliver value through the entire product lifecycle. These insights and the experience of the WestRock Adherence team enable us to work in tune with regulations and clients to provide a service solution underpinned by an innovative and unparalleled range of packaging products including Clinical Trial Packaging, specialty labels, literature & booklets, Adherence packaging, multiple component kits and SMART Digital Adherence Technology.

    Company Website

    To learn more , please visit our website - www.westrock.com/markets/healthcare

    Next Sponsor
    Back

    Company Information

    Scout empowers the life sciences industry with people-first solutions: Scout Meetings, Scout Clinical, and Scout Academy. We specialize in face-to-face, virtual, and hybrid clinical meeting planning, patient payment, travel, and logistics support, and virtual collaboration and education. Since 1995, we have been a trusted partner excelling in customer service, regulatory compliance, and project delivery for leading pharmaceutical and biotechnology companies. Our deep understanding of international regulations and adaptable network of resources is built on operational experience in 109 countries. With white-glove attention to detail and a customizable, comprehensive range of services, Scout makes the complex easier. Learn more at scoutclinical.com.

    Next Sponsor
    Back

    Company Information

    Syneos Health (Nasdaq:SYNH*) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together, we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to lifeTM visit SyneosHealth.com. 

    Company Website

    To learn more , please visit our website - www.SyneosHealth.com

    Next Sponsor
    Back

    Company Information

    Allucent is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas. With more than 30 years of experience in over 60 countries, our individualized partnership approach provides experience-driven insights and expertise to assist clients in successfully navigating the complexities of delivering novel treatments to patients.

    Company Website

    To learn more , please visit our website - www.allucent.com

    Next Sponsor
    Back

    Company Information

    Worldwide is changing how the world experiences CROs – in the best possible way. From early phase, bioanalytical sciences, late phase, post-approval and real-world evidence, Worldwide Clinical Trials provides full-service drug development services for central nervous system, cardiovascular, metabolic, general medicine, oncology and rare disease therapies.

    Company Website

    To learn more , please visit our website - https://www.worldwide.com

    Next Sponsor
    Back

    Company Information

    BSI Life Sciences offers smart eClinical software for CTMS, eTMF and more. BSI makes life science software for people – and has done so for over 25 years. BSI’s software solution is made in Switzerland, Germany, USA and anywhere else clients need to be, and focused on being innovative and user-friendly. They focus on staying ahead of the industry trends and delivering a functional, compliant, and leading edge eClinical solution. This way, BSI helps its customers continuously optimize and accelerate the clinical development process. And that’s what they love! www.bsi-lifesciences.com

    Company Website

    To learn more , please visit our website - www.bsi-lifesciences.com

    Next Sponsor
    Back

    Company Information

    ICON plc is a world-leading healthcare intelligence and clinical research organisation. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organisations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in Dublin, Ireland, ICON employed approximately 41,150 employees in 113 locations in 53 countries as at September 30, 2022.

    Company Website

    To learn more , please visit our website - http://www.iconplc.com/

    Next Sponsor
    Back

    Company Information

    TFS HealthScience is a global Contract Research Organization (CRO) partnering with biotechnology and pharmaceutical companies throughout their entire clinical development journey. Bringing together nearly 700 professionals, we deliver tailored clinical research services in more than 40 countries. TFS supports customers with comprehensive solutions including full clinical development services, strategic and flexible resourcing. In partnership, we build solution-driven teams of experienced professionals working together for a healthier future. Our mission is to bring treatments to patients faster. For more information, please visit www.tfscro.com.

    Company Website

    To learn more , please visit our website - www.tfscro.com.

    Next Sponsor
    Back

    Company Information

    SGS is a leading life sciences CRO providing clinical research and bioanalytical testing with a specific focus on early stage development and biometrics. Delivering solutions in Europe and in Americas, SGS offers clinical trial (Phase I to IV) services encompassing full early phase drug development consultancy, clinical project management and monitoring, biometrics, PK/PD modeling & simulation and regulatory & medical affairs services. SGS has its own clinical unit in Belgium including a viral challenge testing facility and two phase I patients units based in Belgium and Hungary.

    SGS has a wealth of expertise in FIH studies, viral challenge testing, biosimilars and complex PK/PD studies with a high therapeutic focus in Infectious Diseases, Vaccines, and Respiratory.

    Company Website

    To learn more , please visit our website - http://www.sgs.com/en/life-sciences/clinical-research-services

    Next Sponsor
    Back

    Company Information

    Founded in 1997, Ergomed is a full service, global Phase I-IV clinical development and trial management service partner with leading expertise in developing oncology and rare disease drugs.  Our portfolio includes experience working with novel therapies, early phase development, immunotherapy, and adaptive trial designs. Ergomed embodies a patient-centric approach to recruitment and retention with access to global patients in vital geographical areas.  Ergomed’s proven delivery record, expertise, and true partnership means our sponsors can trust us to deliver their oncology trials whatever the challenge. We also offer an industry-leading suite of specialist pharmacovigilance (PV) solutions under the PrimeVigilance brand.

    Ergomed has supported and managed clinical development, trial management, pharmacovigilance, and medical information services for over 300 clients in more than 100 countries.

    We deliver a complete solution for oncology trials of all sizes and complexity. For more information about Ergomed, please visit: www.ergomedcro.com

    Company Website

    To learn more , please visit our website - www.ergomedcro.com

    Next Sponsor
    Back

    Company Information

    Climedo offers a digital platform for hybrid clinical trials and observational studies. Its modular and secure solutions include electronic data capture (EDC), eCOA/ePRO and Telemedicine. This enables pharma and medtech companies to validate their medical innovations more efficiently in the post-market phase and to capture data in decentralized, real-world settings.

    Company Website

    To learn more , please visit our website - www.climedo.de

    Next Sponsor
    Back

    Company Information

    Paitient recruitment services for Sponsors, CROs and Sites.
    We find participants for your clinical trial
    Are you looking for healthy volunteers or patients suffering from diseases such as asthma, diabetes, psoriasis or other indications?
    We have the experience to quickly find suitable local patients and subjects for your study.

    Next Sponsor
    Back

    Company Information

    Greenphire is the industry leader of clinical payment technology, designed to improve the way research professionals work. We leverage our proprietary payments platform and workflow automation to help clients improve operational efficiency, reduce costs, mitigate regulatory risks, improve the patient and site experience and produce quantifiable results that improve clinical operations and strategic planning.

    Company Website

    To learn more , please visit our website - http://greenphire.com/

    Next Sponsor
    Back

    Company Information

    Euromed Pharma deliver strategic services tailored to support companies in their quest to better healthcare. We support each industry player from drug development through the post-marketing phases. We offer solutions in CTS services, Clinical GMP Packaging, Labeling and Distribution, IMP management, Early Access and Named Patient Programs, Pharma Order to cash solutions, and Supply Chain & Logistics. We are present around the world with offices in Italy, Spain, Ireland, Germany, Singapore and the USA. Being one of the Petrone Group companies, Euromed Pharma is positioned at the forefront of innovation in pharmaceutical distribution.

    Company Website

    To learn more , please visit our website - www.euromed-pharma.com

    Next Sponsor
    Back

    Company Information

    NULL

    Company Website

    To learn more , please visit our website - http://www.biomapas.eu

    Next Sponsor

      Why attend?

      ‘Providing a specific platform for the clinical trials community in the DACH region to develop innovative clinical operations and outsourcing strategies’

       

      After a hugely successful 2023 conference, we are pleased to announce that the Outsourcing Clinical Trials DACH event will be returning to zurich. This event will focus upon the operational challenges in clinical development found within Germany, Austria and Switzerland. Over two days, delegates will discuss the common challenges and trends impacting the region, including steps for defining contractual relationships and getting the maximum from external providers, incentivising good relationships with CROs and constructing defined deadlines.

       

      Why Join?

      • Focused conference for the DACH pharma market– Unlike other conferences, our event specifically focuses on the local pharma industry in Switzerland, Germany and Austria, highlighting the current challenges and exciting innovations and opportunities within the market
      • Excellent speaker line up – Senior level speakers from leading organisations such as Roche, AstraZeneca and Novartis along with exciting biotechs like Medac and Medigene
      • Great and Diverse Sessions – Our OCT DACH covers a variety of topics ranging from updated EMA Guidance to Direct to Patient and Data management innovation to CRO relationship
      • Unbeatable Networking Opportunities – Meet and network with over 150 senior industry decision makers during our dedicated networking breaks, round tables and interactive sessions

      WHAT TO EXPECT FOR 2024?

      Join pharma and biotech experts to discuss new trends and opportunities and learn how they optimize their clinical operations enabling you to stay ahead of the game. Find the right solution providers to partner with, allowing you to accelerate your trial timelines.

      200+

      Attendees

      		40+

      Speakers

      		20+

      Exhibitors
      200+

      Attendees

      		40+

      Speakers
      20+

      Exhibitors

      Testimonials

      See What It's All About

      Agenda

      • 29 Oct 2024
      • 30 Oct 2024
      Expand All

      Streams

      Stream one

      Clinical Operations

      Stream two

      Innovation & Technology

      10:30 AM

      Morning refreshments and networking

      11 AM

      CASE STUDY How to succeed with AI in pharma

      • Understanding how to realize uptake of AI and create ROI
      • Building an AI strategy for pharmaceutical companies
      • Enabling AI at large

      Speakers

      Benjamin Torben-Nielsen
      Corporate Strategy, Roche

      11:30 AM

      Session reserved event sponsor

      12 PM

      Integrating digital health technologies in clinical trials

      • Improving recruitment and adherence with digital tools
      • Streamlining and securing data analysis with digital platforms
      • Ensuring compliance with digital documentation and reporting

       

      Speakers

      Jade Sternberg
      Digital Health Lead, Digital Switzerland

      12:30 PM

      15-minute Tech Spotlight

      15-minute Tech Spotlight
      Session reserved for event sponsor

      15-minute Tech Spotlight
      Session reserved for event sponsor

      12:45 PM

      15-minute Tech Spotlight: Re-discovering the patient journey in decentralized clinical trials

       

       

      • Role of patient-centered, dynamic, and intuitive symptom tracking as well as corresponding ePROs in decentralized clinical trial settings
      • Medidux patient platform : Accurate, timely, and integrated data collection
        • Enrichment of data through IoT wearables & laboratory parameters
      • Medidux reports: Enabling efficient patient-physician collaboration
        • Ensuring ePRO reliability through patient-physician symptom review
        • Towards an Early Warning System in “patient at home” settings

      Speakers

      Prof. Dr. med. Andreas Trojan
      Co-Founder and CMO, Mobile Health AG, Medical Oncologist and Leading Physician, Breast Center Zürichsee

      1 PM

      Lunch and networking

      2 PM

      Innovative thinking for increasing patient diversity and inclusion in clinical trials

      • Increasing diversity in clinical trial patient recruitment
      • Understanding why diversity in clinical trials is important for trial outcomes
      • Exploring how to advance medicine through increased diversity

      Speakers

      Antonio Bebba
      DE&I Regional Operations Lead (Europe), Pfizer

      2:30 PM

      Session reserved for event sponsor

      3 PM

      Fostering a culture of quality in clinical research: a catalyst for innovation

      • Is there any area where quality is more paramount than in clinical research?
      • Are the traditional quality management tools and metrics the right approach?
      • Exploring what embeds quality deep in the clinical research culture

      Speakers

      Effie Pournara
      Senior Global Medical Director, Novartis

      3:30 PM

      Afternoon refreshments and networking

      4 PM

      CASE STUDY Leveraging AI to enhance real-world evidence (RWE) data collection and analysis – lessons learned

      • Discussing methods for leveraging AI to integrate diverse real-world evidence data source

      • Exploring how AI-driven techniques can standardize heterogeneous data streams and improve data quality

      4:30 PM

      PANEL DISCUSSION Exploring the transition of innovation & technological advancements in clinical trials

      • Are we making the most of technology & innovation in the clinical trial space?
      • How are these tools being utilized efficiently?
      • The importance of exploring ethical considerations
      • Examining the relationship between innovation, creativity, and regulations
      • What’s next?

      Speakers

      Benjamin Torben-Nielsen
      Corporate Strategy, Roche

      8 AM

      Registration and refreshments

      8:40 AM

      Chairperson’s opening remarks

      9 AM

      Navigating ICH GCP V3 regulatory requirements: updates and best practices

      • Understanding the latest changes in ICH GCP V3 regulatory requirements in a user-friendly manner
      • Implementing effective compliance measures to ensure alignment with evolving regulatory expectations
      • Identifying key challenges and ways to overcome them

       

      TBD - Nicolas Le Bec, Director, Therapeutic Area Quality Lead, Global R&D Quality, Bristol Myers Squibb

      9:30 AM

      Session reserved for event sponsor

      10 AM

      Session reserved for event sponsor

      10:30 AM

      Morning refreshments and networking Sponsored by Aixial

      11 AM

      PANEL DISCUSSION Revitalizing clinical trials in the DACH region: overcoming challenges and enhancing attractiveness

      • Identify the key challenges that make DACH region less attractive for clinical trials
      • Strategies to make the region more appealing for global trials, focusing on speeding up processes, reducing costs, and leveraging technology for efficiency and inclusivity
      • Discuss the consequences of low participation in clinical trial
      • Present strategies to streamline administrative processes and reduce bureaucracy
      • Explore methods to enhance patient recruitment and retention

      Panelists

      Cornelia Baumgartner, Clinical Operations Lead, T-CURX
      Ina Meyer, Study & Site Operations Country Lead Switzerland, Global Clinical Operations, Novartis
      Andrea Sauerland, Senior Director Clinical Operations, Endotronix
      Nicolas Schneider, Director Clinical Operations and Alliance Management, ITM Isotopen Technologien München

      Speakers

      Cornelia Baumgartner
      Diolaiuti, Clinical Operation Manager, T-CURX
      Ina Meyer
      Study & Site Operations Country Lead Switzerland, Global Clinical Operations, Novartis
      Andrea Sauerland
      Senior Director Clinical Operations, Endotronix
      Dr. Nicolas Schneider
      Director Clinical Operations and Alliance Management, ITM Isotopen Technologien München

      11:30 AM

      Session reserved event sponsor

      12 PM

      Aspects to contemplate when selecting a CRO for rare disease trials

      • • Does possessing therapeutic expertise remain imperative in choosing a CRO for a rare disease inquiry?
        • Evaluating the advantages of niche specialized CROs versus expansive multinational CROs
        • Extra hurdles in the CRO selection procedure arise when addressing ultra-rare diseases, where CROs may lack familiarity with the condition
        • Discussing the merits and drawbacks of engaging a comprehensive service CRO for your rare disease examination versus collaborating with various vendors across the study

      Speakers

      Christoph Gasteyger
      Executive Director, Global Program Team Lead Hematology/Nephrology, Alexion

      12:30 PM

      Session reserved for event sponsor

      1 PM

      Lunch and networking

      2 PM

      Q&A session What do venture capitalists look for in startups? Unveiling the main criteria for investment

      Speakers

      Nadiia Wyttenbach
      Managing Director, Growth Equity, Redalpine

      2:30 PM

      Session reserved for event sponsor

      3 PM

      Developing the first treatment for my own ultra-rare disease – lessons learned

      • Meaningful involvement of patients in the study design phase to reflect their needs and improve trial execution
      • Ethical aspects of trial designs in ultra-rare diseases
      • Partnering with patient advocacy groups to foster meaningful relationships
      • Experiences and lessons learned from being a patient representative in regulatory approval and HTA proceedings

      Speakers

      Dr. Jasmin Barman-Aksözen
      Research Investigator, Lecturer and Rare Disease Patient Advocate, University of Zurich

      3:30 PM

      Afternoon refreshments and networking

      4 PM

      Key considerations and strategic steps to ensure successful and timely execution when planning a startup

      • Understanding the timeline from the initial idea to the first patient enrolment
      • Assembling a powerful team within your company
      • Creating a realistic project plan and budget
      • Gaining a thorough understanding of the regulatory and competitive landscape
      • Carefully considering the design of your trial, patient availability, the number of patients needed, and the number of sites/countries involved
      • Choosing the right partners, including CROs, vendors, and sites

      Speakers

      Cornelia Baumgartner
      Diolaiuti, Clinical Operation Manager, T-CURX

      4:30 PM

      PANEL DISCUSSION Enhancing communication between CROs, sponsors and clinical trial sites for an efficient work process

      • Emphasizing the importance of defining clear communication channels, expectations, and escalation procedures among CROs, sponsors, and sites to ensure transparency and accountability throughout the trial
      • Highlighting the benefits of leveraging communication technologies such as centralized platforms and project management tools to facilitate real-time information sharing and collaboration among stakeholders
      • Providing training and resources to enhance communication skills and promote effective teamwork across all levels

      Speakers

      Christoph Gasteyger
      Executive Director, Global Program Team Lead Hematology/Nephrology, Alexion
      Monika Gawlowicz
      MD Investigator, Pratia
      Judit Magos
      Clinical Operations Manager, Idorsia Pharmaceuticals

      5:15 PM

      Chairperson’s closing remarks

      Speakers

      Dr. Frank Richard
      MD, MBA, Senior Medical Director, Sotio Biotech

      DRINKS RECEPTION

      8 AM

      Registration and refreshments

      8:50 AM

      Chairperson’s opening remarks

      9 AM

      PANEL DISCUSSION The clinical trial landscape for small to mid-sized biopharma in the DACH region

      • New regulations and guidance around clinical trials in the DACH region: how will this impact you?
      • Staff turnover and layoffs: handling changes in the industry in order to ensure success
      • Navigating the constantly evolving vendor and CRO landscape as a small to mid sized sponsor company
      • An overview of technology and innovation in the clinical trial industry: what’s working and what isn’t?

      9:45 AM

      Session reserved for event sponsor

      10:15 AM

      FIRESIDE CHAT Ensuring adequate sponsor oversight of clinical trials when outsourced to clinical contract research organisations

      • Ensuring that KPIs are informative and meaningful.
      • Assessing overall project risk and appropriate surveillance tactics
      • Consolidating your overall management strategy that can be coordinated with CRO SOPs
      • Providing documentation of Sponsor oversight activities throughout the study

      Speakers

      Judit Magos
      Clinical Operations Manager, Idorsia Pharmaceuticals

      10:45 AM

      Morning refreshments and networking

      11:15 AM

      CASE STUDY Optimizing study initiation and feasibility assessment under the CTIS framework

      • Identifying EU countries with the fastest approval times for clinical trials under CTIS, and understanding their streamlined processes
      • Analysing which countries typically ask the most questions during the feasibility assessment and initiation phases, and developing strategies for efficiently addressing these inquiries
      • Leveraging regulatory consulting to enhance CTIS navigation, including tips on documentation, compliance, and communication to expedite trial initiation and minimize delays

      Speakers

      Dr Sol Yates
      Associate Director, European Regulatory Affairs, Shionogi Europe

      11:45 AM

      FIRESIDE CHAT Enhancing site accessibility and collaboration in clinical trials to reduce burden on sites

      • Understanding the resource constraints faced by trial sites and the impact on their accessibility and participation in clinical studies
      • Promoting flexibility in data management by accommodating both paper and electronic platforms based on site preferences, ensuring smoother integration and reduced burden on site staff
      • Encouraging open communication with sites to understand their specific needs and preferences

      Speakers

      Ina Meyer
      Study & Site Operations Country Lead Switzerland, Global Clinical Operations, Novartis

      12:15 PM

      Session reserved for event sponsor

      12:45 PM

      Lunch and networking

      1:45 PM

      Artificial Intelligence in Pharma

      • Brief overview of AI/GenAI market, including current limitations and technology roadmap
      • AI and its applications in Healthcare, from business processes to use cases
      • Models to acquire GenAI capabilities
      • GenAI delivery models
      • Risks, costs and other considerations

      Thematic Intelligence speaker, GlobalData

      2:15 PM

      Session Reserved for Event Sponsor

      2:45 PM

      Financial oversight of clinical studies and development to optimize cost savings

      • Creating a cost optimized study set-up to work more effectively
      • Reviewing selection processes and negotiations with your vendor
      • Management and closure of study budget

      Speakers

      Clare Price
      Clinical Operations Leader, CDR-Li

      3:15 PM

      Afternoon refreshments and networking

      4 PM

      PROBLEM-SOLVING ROUNDTABLE DISCUSSIONS

      During the roundtable discussion session, the conference hall will be divided into two ‘zones’. Delegates can choose which zone they would like to join. Each zone will be led by a table moderator and will focus on a different challenge within clinical operations in oncology trials. After 30 minutes, delegates will have the opportunity to swap and choose a different table, and each roundtable will run twice.

      ROUNDTABLE 1
      Exploring ways to involve patients in clinical trials to advance patient recruitment and retention with regulatory considerations
      Dr. Jasmin Barman-Aksözen, Research Investigator, Lecturer and Rare Disease Patient Advocate, University of Zurich

      ROUNDTABLE 2
      How can we be more efficient in clinical operations with less resources?
      Nicolas Schneider, Director Clinical Operations and Alliance Management, ITM Isotopen Technologien München

      ROUNDTABLE 3
      Considering the future of DCTs vs hybrid trials

      ROUNDTBALE 4
      Considerations to make clinical trials more environmental and social sustainable

      END OF CONFERENCE

      5 PM

      Chairperson’s closing remarks

      Speakers

      Dr. Frank Richard
      MD, MBA, Senior Medical Director, Sotio Biotech

      Speakers

      Select a speaker to learn more

      Back
      Cornelia Baumgartner
      Diolaiuti, Clinical Operation Manager, T-CURX

      Session Details:

      PANEL DISCUSSION Revitalizing clinical trials in the DACH region: overcoming challenges and enhancing attractiveness

      2024-10-29, 11:00 AM

      Session Details:

      Key considerations and strategic steps to ensure successful and timely execution when planning a startup

      2024-10-29, 4:00 PM

      View In Agenda
      Next speaker
      Back
      Christoph Gasteyger
      Executive Director, Global Program Team Lead Hematology/Nephrology, Alexion

      Session Details:

      PANEL DISCUSSION Enhancing communication between CROs, sponsors and clinical trial sites for an efficient work process

      2024-10-29, 4:30 PM

      Session Details:

      Aspects to contemplate when selecting a CRO for rare disease trials

      2024-10-29, 12:00 PM

      View In Agenda
      Next speaker
      Back
      Nadiia Wyttenbach
      Managing Director, Growth Equity, Redalpine

      Session Details:

      Q&A session What do venture capitalists look for in startups? Unveiling the main criteria for investment

      2024-10-29, 2:00 PM

      View In Agenda
      Next speaker
      Back
      Monika Gawlowicz
      MD Investigator, Pratia

      Session Details:

      PANEL DISCUSSION Enhancing communication between CROs, sponsors and clinical trial sites for an efficient work process

      2024-10-29, 4:30 PM

      View In Agenda
      Next speaker
      Back
      Antonio Bebba
      DE&I Regional Operations Lead (Europe), Pfizer

      Session Details:

      Innovative thinking for increasing patient diversity and inclusion in clinical trials

      2024-10-29, 2:00 PM

      View In Agenda
      Next speaker
      Back
      Benjamin Torben-Nielsen
      Corporate Strategy, Roche

      Session Details:

      CASE STUDY How to succeed with AI in pharma

      2024-10-29, 11:00 AM

      Session Details:

      PANEL DISCUSSION Exploring the transition of innovation & technological advancements in clinical trials

      2024-10-29, 4:30 PM

      View In Agenda
      Next speaker
      Back
      Dr. Jasmin Barman-Aksözen
      Research Investigator, Lecturer and Rare Disease Patient Advocate, University of Zurich

      Session Details:

      Developing the first treatment for my own ultra-rare disease – lessons learned

      2024-10-29, 3:00 PM

      View In Agenda
      Next speaker
      Back
      Ina Meyer
      Study & Site Operations Country Lead Switzerland, Global Clinical Operations, Novartis

      Session Details:

      PANEL DISCUSSION Revitalizing clinical trials in the DACH region: overcoming challenges and enhancing attractiveness

      2024-10-29, 11:00 AM

      Session Details:

      FIRESIDE CHAT Enhancing site accessibility and collaboration in clinical trials to reduce burden on sites

      2024-10-30, 11:45 AM

      View In Agenda
      Next speaker
      Back
      Andrea Sauerland
      Senior Director Clinical Operations, Endotronix

      Session Details:

      PANEL DISCUSSION Revitalizing clinical trials in the DACH region: overcoming challenges and enhancing attractiveness

      2024-10-29, 11:00 AM

      View In Agenda
      Next speaker
      Back
      Dr Sol Yates
      Associate Director, European Regulatory Affairs, Shionogi Europe

      Session Details:

      CASE STUDY Optimizing study initiation and feasibility assessment under the CTIS framework

      2024-10-30, 11:15 AM

      View In Agenda
      Next speaker
      Back
      Dr. Nicolas Schneider
      Director Clinical Operations and Alliance Management, ITM Isotopen Technologien München

      Session Details:

      PANEL DISCUSSION Revitalizing clinical trials in the DACH region: overcoming challenges and enhancing attractiveness

      2024-10-29, 11:00 AM

      View In Agenda
      Next speaker
      Back
      Effie Pournara
      Senior Global Medical Director, Novartis

      Session Details:

      Fostering a culture of quality in clinical research: a catalyst for innovation

      2024-10-29, 3:00 PM

      View In Agenda
      Next speaker
      Back
      Judit Magos
      Clinical Operations Manager, Idorsia Pharmaceuticals

      Session Details:

      PANEL DISCUSSION Enhancing communication between CROs, sponsors and clinical trial sites for an efficient work process

      2024-10-29, 4:30 PM

      Session Details:

      FIRESIDE CHAT Ensuring adequate sponsor oversight of clinical trials when outsourced to clinical contract research organisations

      2024-10-30, 10:15 AM

      View In Agenda
      Next speaker
      Back
      Clare Price
      Clinical Operations Leader, CDR-Li

      Session Details:

      Financial oversight of clinical studies and development to optimize cost savings

      2024-10-30, 2:45 PM

      View In Agenda
      Next speaker
      Back
      Jade Sternberg
      Digital Health Lead, Digital Switzerland

      Session Details:

      Integrating digital health technologies in clinical trials

      2024-10-29, 12:00 PM

      View In Agenda
      Next speaker

      Plan Your Visit

      Hyatt Regency Zurich Airport The Circle

      The Circle 41 Kloten 8058 Switzerland

      Book Your Stay

      Accommodation

      Arena International Events Group “(Arena”) is aware of numerous third party agencies which are contacting Arena’s customers and purporting to have access to hotel room bookings and events attendee lists. It is unclear whether the agencies in question are in possession of such information, or whether they intend to scam unsuspecting customers. Whilst Arena International Events Group pursues such third party companies for their potentially illicit activity, Arena encourages you to be cautious in engaging with such third party agencies and Arena shall not accept any responsibility for any losses incurred by you should you choose to engage with third parties that have no affiliation to Arena International Events Group.

      Sponsors

      Select a sponsor to learn more

      FEATURED SPONSOR

      SESSION SPONSOR

      Exhibitors

      Technology Spotlight Sponsor

      CO-SPONSOR

      Why partner?

       

      Contact us to become a partner

      Partnership Opportunities

      We work with you to design a bespoke package to meet your business needs, where you could:

      • Demonstrate your expertise on the agenda – have the attention of the entire audience. For greatest impact, why not position your talk before a networking break and immediately conduct follow up conversations with highly engaged attendees
      • Showcase your business and its services at an exhibition booth, which provides a perfect meeting place for prospective new clients
        Present the value proposition of your offering over your competitors, in front of an audience of active, engaged potential customers
      • Speak with key decision makers as part of our intimate, interactive roundtable style workshop sessions with over 8 hours allowed for networking

      Event reach

      • 200+ attendees each year
      • 80% attendees C-suite level

       

      Take a look at our current sponsors

      Media Centre

      MEDIA PARTNERS

      Become A Media Partner

      WHAT TO EXPECT FOR 2023

      Join pharma and biotech experts to discuss new trends and opportunities and learn how they optimize their clinical operations enabling you to stay ahead of the game.

       

      Find the right solution providers to partner with, allowing you to accelerate your trial timelines.

      See What It's All About

      Enquiry

      Contact Us

      SPONSORSHIP ENQUIRIES

      Alex Purnell

      Senior Sponsorship Manager

      +44 204540 7786

      SPEAKER ENQUIRIES

      Ralitsa Pashkuleva

      Conference Producer

      MARKETING ENQUIRIES

      Moona Popal

      Marketing Manager

      DELEGATE ENQUIRIES

      Sunny Saikia

      VIP Delegate Manager

      SPONSORSHIP ENQUIRIES

      To enquire about sponsorship opportunities for the conference, please contact:

      Alex Purnell

      Senior Sponsorship Manager


      +44 204540 7786

      SPEAKER ENQUIRIES

      To enquire about speaking opportunities for the conference, please contact:

      Ralitsa Pashkuleva

      Conference Producer